| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $59.7M | +10.0% |
| Cost of Revenue | $12.0M | +28.7% |
| Gross Profit | $47.6M | +6.1% |
| R&D Expense | $20.7M | +57.5% |
| SG&A Expense | $37.6M | +110.1% |
| Operating Income | -$40.3M | -3651.9% |
| Pre-tax Income | -$38.9M | -7731.4% |
| Income Tax | $484K | -41.4% |
| Net Income | -$39.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.6M | +343.5% |
| Accounts Receivable | $9.2M | +129.9% |
| Current Assets | $107.3M | +413.6% |
| Total Assets | $142.3M | +248.2% |
| Current Liabilities | $34.5M | +38.0% |
| Total Liabilities | $42.3M | +34.2% |
| Stockholders' Equity | $100.1M | +964.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.8M | -1775.8% |
| Capital Expenditures | $505K | +49.0% |
| Investing Cash Flow | -$66.5M | — |
| Financing Cash Flow | $101.3M | +6232.0% |
| Free Cash Flow | -$20.3M | -2511.3% |
| — |
| EPS (Basic) | -$1.53 | -7550.0% |
| EPS (Diluted) | -$1.53 | -7550.0% |